Related Experiment Videos
Risk factors for neonatal hyperbilirubinemia
W Phuapradit1, K Chaturachinda, S Auntlamai
1Department of Obstetrics & Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Summary
Neonatal hyperbilirubinemia, a common newborn condition, is linked to several delivery factors including vacuum extraction and preterm birth. Increased oxytocin use may also contribute to its rising incidence.
Area of Science:
- Neonatalogy
- Obstetrics
- Public Health
Background:
- Neonatal hyperbilirubinemia is a frequent condition in newborns.
- Understanding associated risk factors is crucial for prevention and management.
- Observed trends in incidence warrant investigation into contributing obstetric practices.
Purpose of the Study:
- To identify and analyze factors associated with neonatal hyperbilirubinemia.
- To investigate the relationship between specific obstetric interventions and hyperbilirubinemia.
- To examine trends in neonatal hyperbilirubinemia incidence over a five-year period.
Main Methods:
- Historical prospective study design.
- Data collection from labor and patient records at Ramathibodi Hospital (1988).
- Statistical analysis to determine relative risks (RR) for various factors.
Main Results:
- Significant positive relationships found between neonatal hyperbilirubinemia and vacuum extraction (RR 2.7), preterm delivery (RR 2.1), low birthweight (RR 2.0), antepartum complications (RR 1.7), intrapartum complications (RR 1.5), forceps delivery (RR 1.4), and oxytocin infusion (RR 1.3).
- No significant association with fetal sex, cesarean section, breech delivery, or 5-minute Apgar score.
- A notable increase in hyperbilirubinemia incidence from 1984-1988 correlated with increased oxytocin use.
Conclusions:
- Several obstetric interventions and complications are significant risk factors for neonatal hyperbilirubinemia.
- The rise in neonatal hyperbilirubinemia incidence may be linked to changing obstetric practices, specifically increased oxytocin infusion.
- Recommendations include educating obstetricians on these risks and auditing oxytocin use.